| ENTHEON BIOMEDICAL CORP. |
| Kanada |
| Gesundheit |
| CA29383X2023 / A404YT |
| 1XU (Frankfurt) |
| FRA:1XU, ETR:1XU, 1XU:GR |
| - |
| https://www.entheonbiomed.. |
|
Entheon Biomedical Corp. is a biotechnology company focused on researching and developing innovative solutions for mental health disorders. The company specializes in psychedelic therapies, exploring the use of compounds like DMT (Dimethyltryptamine)..
>Volltext.. |
| 0.85 Mio. EUR |
| 0.61 Mio. EUR |
| - |
| -0.22 Mio. EUR |
| -0.21 Mio. EUR |
| -0.02 EUR |
| - |
| 0.24 Mio. EUR |
| -0.21 Mio. EUR |
| 20.75 |
| - |
| -3.53% |
| - |
| - |
| - |
| - |
| ENTHEON |
| 02.04.26 |
|